ha14-1 has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 2 studies
ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate: a BH3 mimetic; synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiffar, T | 1 |
| Kurinna, S | 1 |
| Suck, G | 1 |
| Carlson-Bremer, D | 1 |
| Ricciardi, MR | 1 |
| Konopleva, M | 1 |
| Andreeff, M | 1 |
| Ruvolo, PP | 1 |
| Su, Y | 1 |
| Zhang, X | 1 |
| Sinko, PJ | 1 |
2 other studies available for ha14-1 and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
PKC alpha mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation.
Topics: Antineoplastic Agents, Phytogenic; Benzopyrans; Cell Cycle; Drug Resistance, Neoplasm; Enzyme Inhibi | 2004 |
Exploitation of drug-induced Bcl-2 overexpression for restoring normal apoptosis function: a promising new approach to the treatment of multidrug resistant cancer.
Topics: Apoptosis; Benzopyrans; Caspases; DNA Fragmentation; Drug Resistance, Multiple; Enzyme Activation; G | 2007 |